Literature DB >> 17440674

Prediction of bone loss using biochemical markers of bone turnover.

J Lenora1, K K Ivaska, K J Obrant, P Gerdhem.   

Abstract

UNLABELLED: The association between baseline levels of eleven bone turnover markers and 5-year rate of bone density change was prospectively studied in a population-based sample of 601 75-year-old women. Several bone formation and resorption markers as well as urinary osteocalcin were modestly correlated to rate of bone density change.
INTRODUCTION: Prediction of bone loss by bone turnover markers (BTMs) has been investigated with conflicting results. There is limited information in the elderly.
METHODS: Eleven bone turnover markers were analyzed in 75-year old women in the OPRA study (n = 601) and compared to the 5-year change of areal bone mineral density (aBMD) in seven skeletal regions.
RESULTS: Annual aBMD change varied between +0.4% (spine) and -2.0% (femoral neck). Significant associations (p < 0.01) were found for four different serum osteocalcins (S-OCs) (standardized regression coefficient -0.20 to -0.22), urinary deoxypyridinoline (-0.19), serum TRACP5b (-0.19), serum CTX-I (-0.21), two of the three urinary osteocalcins (U-OCs) (-0.16) and aBMD change of the leg region (derived from the total body measurement). After adjustment for baseline aBMD, associations were found for all S-OCs (-0.11 to -0.16), two of the three U-OCs (-0.14 to -0.16) and aBMD change at the total hip, and for three of the four S-OCs (-0.14 to -0.15), S-TRACP5b (-0.11), two of the three U-OCs (-0.14 to -0.15) and aBMD change at the femoral neck. There were no significant results concerning aBMD change at the spine.
CONCLUSION: This study indicates that BTMs are correlated with aBMD loss in some skeletal regions in elderly women.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440674     DOI: 10.1007/s00198-007-0379-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  38 in total

1.  Determinants of bone loss in elderly men and women: a prospective population-based study.

Authors:  E Dennison; R Eastell; C H Fall; S Kellingray; P J Wood; C Cooper
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

2.  Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum.

Authors:  S M Käkönen; J Hellman; M Karp; P Laaksonen; K J Obrant; H K Väänänen; T Lövgren; K Pettersson
Journal:  Clin Chem       Date:  2000-03       Impact factor: 8.327

3.  Biochemical markers of bone turnover predict bone loss in perimenopausal women but not in postmenopausal women-the Japanese Population-based Osteoporosis (JPOS) Cohort Study.

Authors:  M Iki; A Morita; Y Ikeda; Y Sato; T Akiba; T Matsumoto; H Nishino; S Kagamimori; Y Kagawa; H Yoneshima
Journal:  Osteoporos Int       Date:  2006-05-03       Impact factor: 4.507

4.  Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures.

Authors:  D C Bauer; P M Sklarin; K L Stone; D M Black; M C Nevitt; K E Ensrud; C D Arnaud; H K Genant; P Garnero; P D Delmas; H Lawaetz; S R Cummings
Journal:  J Bone Miner Res       Date:  1999-08       Impact factor: 6.741

5.  Biochemical markers of bone turnover are influenced by recently sustained fracture.

Authors:  Karl J Obrant; Kaisa K Ivaska; Paul Gerdhem; Sari L Alatalo; Kim Pettersson; H Kalervo Väänänen
Journal:  Bone       Date:  2005-03-31       Impact factor: 4.398

6.  Femoral neck bone loss predicts fracture risk independent of baseline BMD.

Authors:  Tuan V Nguyen; Jacqueline R Center; John A Eisman
Journal:  J Bone Miner Res       Date:  2005-02-21       Impact factor: 6.741

7.  Interest of biochemical markers of bone turnover for long-term prediction of new vertebral fracture in postmenopausal osteoporotic women.

Authors:  Olivier Bruyere; Julien Collette; Pierre Delmas; Alain Rouillon; Christian Roux; Laurence Seidel; Florent Richy; Jean Yves Reginster
Journal:  Maturitas       Date:  2003-04-25       Impact factor: 4.342

8.  Markers of bone remodeling predict rate of bone loss in multiple sclerosis patients treated with low dose glucocorticoids.

Authors:  Jan J Stepan; Eva Havrdová; Michaela Týblová; Dana Horáková; Veronika Tichá; Iveta Nováková; Vít Zikán
Journal:  Clin Chim Acta       Date:  2004-10       Impact factor: 3.786

9.  Identification of novel proteolytic forms of osteocalcin in human urine.

Authors:  Kaisa K Ivaska; Jukka Hellman; Johanna Likojärvi; Sanna-Maria Käkönen; Paul Gerdhem; Kristina Akesson; Karl J Obrant; Kim Pettersson; H Kalervo Väänänen
Journal:  Biochem Biophys Res Commun       Date:  2003-07-11       Impact factor: 3.575

10.  Relationship between changes in biochemical markers of bone turnover and BMD to predict vertebral fracture risk.

Authors:  Somnath Sarkar; Jean-Yves Reginster; Gerald G Crans; Adolfo Diez-Perez; Karen V Pinette; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2003-12-22       Impact factor: 6.741

View more
  28 in total

1.  Successes achieved and challenges ahead in translating biomarkers into clinical applications.

Authors:  Greg Tesch; Shashi Amur; John T Schousboe; Jeffrey N Siegel; Lawrence J Lesko; Jane P F Bai
Journal:  AAPS J       Date:  2010-03-16       Impact factor: 4.009

2.  Differential effects of calcium- and vitamin D-fortified milk with FOS-inulin compared to regular milk, on bone biomarkers in Chinese pre- and postmenopausal women.

Authors:  Marlena C Kruger; Yoke Mun Chan; Barbara Kuhn-Sherlock; Lee Ting Lau; ChinChin Lau; Y S Chin; Joanne M Todd; Linda M Schollum
Journal:  Eur J Nutr       Date:  2015-08-12       Impact factor: 5.614

3.  Intradialytic Calcium Kinetics and Cardiovascular Disease in Chronic Hemodialysis Patients.

Authors:  Markus Pirklbauer; Lisa Fuchs; Ramona Heiss; Thomas Ratschiller; Gert Mayer
Journal:  Blood Purif       Date:  2020-07-24       Impact factor: 2.614

4.  Considerations for development of surrogate endpoints for antifracture efficacy of new treatments in osteoporosis: a perspective.

Authors:  Mary L Bouxsein; Pierre D Delmas
Journal:  J Bone Miner Res       Date:  2008-08       Impact factor: 6.741

5.  Bone turnover markers are correlated with quantitative ultrasound of the calcaneus: 5-year longitudinal data.

Authors:  J Lenora; P Gerdhem; K J Obrant; K K Ivaska
Journal:  Osteoporos Int       Date:  2008-10-23       Impact factor: 4.507

6.  Reference intervals of bone turnover markers determined by using their curve-fitting valley for adult females in China.

Authors:  X-Y Wu; H Zhang; H Xie; X-H Luo; Y-Q Peng; L-Q Yuan; R-C Dai; Z-F Sheng; X-P Wu; E-Y Liao
Journal:  Osteoporos Int       Date:  2013-07-23       Impact factor: 4.507

7.  Polymorphisms in the macrophage migration inhibitory factor gene and bone loss in postmenopausal women.

Authors:  Maria Swanberg; Fiona McGuigan; Kaisa K Ivaska; Paul Gerdhem; Ulf H Lerner; Richard Bucala; George Kuchel; Anne Kenny; Kristina Akesson
Journal:  Bone       Date:  2010-05-12       Impact factor: 4.398

Review 8.  Bone markers in osteoporosis.

Authors:  Patrick Garnero
Journal:  Curr Osteoporos Rep       Date:  2009-09       Impact factor: 5.096

9.  Prediction of bone loss in elderly female subjects by MR perfusion imaging and spectroscopy.

Authors:  James F Griffith; David K W Yeung; Jason Chi Shun Leung; Timothy C Y Kwok; Ping C Leung
Journal:  Eur Radiol       Date:  2011-01-13       Impact factor: 5.315

Review 10.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.